Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

THE LIVINGSTON GROUP, LLC OBO INNOVATIVE VACCINE TECHNOLOGIES

Filed by OCULUS STRATEGIES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
0ed19f39-0b81-420b-949a-8f6a456ce9c9
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

DEF · Defense

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S ___, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Literal federal measure citations: HR 3838, S 2296, HR 4016

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.